Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2003
03/13/2003US20030049326 Bone graft material incorporating demineralized bone matrix and lipids
03/13/2003US20030049288 Method for producing a cosmetically applicable marine mud extract and product containing said marine mud extract
03/13/2003US20030049264 Releasing neurotransmitters; analgesics
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049242 Decorated red blood cells
03/13/2003US20030049240 Pet food composition for treating helicobacter species in pets
03/13/2003US20030049238 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/13/2003US20030049236 Therapy for bone disorders; transduction, cell differentiation
03/13/2003US20030049235 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
03/13/2003US20030049234 Discovery, localization, harvest, and propagation of an fgf2 and bdnf-responsive population of neural and neuronal progenitor cells in the adult human forebrain
03/13/2003US20030049233 Culture product; accumulation device containing electroconductive rod; nonconductor handle
03/13/2003US20030049232 Administering mixture of red blood cells and hemoglobin solution
03/13/2003US20030049231 Therapy for skin disorders; human or veterinary medicine
03/13/2003US20030049206 Administering biocompatible-labeled embryonic stem cells to the patient via intravenous injection, and detecting said stem cells to identify tumors in the patient where said stem cells have accumulated
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2459957A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003CA2459728A1 Late gestation lung genes, fragments and uses thereof
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/12/2003EP1291415A1 Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state
03/12/2003EP1291414A1 Ex vivo selection of T-cells with reduced alloreactivtiy (diminshed graft-versus-host effect and enhanced graft-verus-leukemia effect) and use therof in bone marrow transplantations
03/12/2003EP1291088A2 Blood processing systems and methods for collecting mono nuclear cells
03/12/2003EP1291020A2 Use of cytokines and mitogens to inhibit pathological immune responses
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290182A1 Sphingosine kinase and uses thereof
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290145A2 Three-dimensional skin model
03/12/2003EP1290144A2 Infection model
03/12/2003EP1290143A2 Method to determine the differentiation potential of a target cell
03/12/2003EP1290141A2 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1289999A1 Antitumoral analogs of et-743
03/12/2003EP1289574A2 Cartilage replacement and methods for the production thereof
03/12/2003EP1289553A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003EP1289540A2 Methods and compositions for producing a neurosalutary effect in a subject
03/12/2003EP1289536A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
03/12/2003EP1289535A2 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289446A2 Cardiac disease treatment and device
03/12/2003EP1289383A1 Primary composition containing a lipophilic bioactive compound
03/12/2003EP1263418A4 Cartilage enhancing food supplements and methods of preparing the same
03/12/2003EP1137430B1 Therapeutic agent for the suppression of snoring noises
03/12/2003EP0881886B1 Animal feed
03/12/2003EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase
03/12/2003EP0781095B1 Cells bearing cd4 decoy receptors and related molecules and methods
03/12/2003EP0669973B1 Biological factors and neural stem cells
03/12/2003EP0642301B1 Pharmaceutically acceptable fixed-dried human blood platelets
03/12/2003CN1402782A MAGE-A12 antigenic peptides and uses thereof
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1401386A Chinese medicine for removing intense heat from throat and dysphagia, and preparing process there
03/12/2003CN1401383A Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof
03/12/2003CN1401375A Medicine for preventing and treating intestinal adhesion in abdominal operation, and preparing method thereof
03/12/2003CN1401367A Ointment for intervertebral disc
03/12/2003CN1401366A Chinese medicinal herbs ointment and preparing method thereof
03/12/2003CN1401362A Medical preparation of treating necrosis of femoral head
03/12/2003CN1401360A Chinese medicine ointment for treating arthrosis
03/12/2003CN1401358A Medicine for treating hepatitis, and preparing process thereof
03/12/2003CN1401357A External applied medical ointment for treating piles
03/12/2003CN1401353A Chinese medicinal herbs preparation 'Shuzetong' for treating hydrops
03/12/2003CN1401350A Medicine for treating burns and scald, and producing method thereof
03/12/2003CN1401349A Formulation of tumor treating capsule, and inspecting method thereof
03/12/2003CN1401347A Brain and heart recovery pill
03/12/2003CN1401346A Numbness- and pain-eliminating capsule and preparing method thereof
03/12/2003CN1401343A Chinese medicine compound preparation for treating cervical spondylosis, and preparing process thereof
03/12/2003CN1401341A Medicinal powder 'Pianfusan' for treating hemiplegia
03/12/2003CN1401336A Medicine of treating dermatosis for external use
03/12/2003CN1401335A Medicine for withdrawal of drug addiction and preparing process thereof
03/12/2003CN1401333A Process for producing biopreparation with special acne, comedo and folliculitis treatment effect
03/12/2003CN1401332A Medicine for treating osteomyelitis and lymphoid tuberculosis, and making process thereof
03/12/2003CN1401331A Method for wall-breaking leaching ganoderma spore powder
03/12/2003CN1401330A Buccal red deer horn tablet
03/12/2003CN1401315A Cold spring volcanic mud and pure bioactive factor composition and producing method thereof
03/12/2003CN1102855C Immunotherapeutic composition
03/12/2003CN1102853C Tumor metastasis suppressing agent and veterinary tumor metastasis suppressing agent
03/12/2003CN1102851C Plasma like solution
03/11/2003USRE38027 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
03/11/2003US6531453 Activating human NKT cell by culturing in vitro mononuclear cell fraction comprising human NKT cell in presence of specified compound or salt or solvate thereof
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531445 Protein-induced morphogenesis in liver tissue
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531307 Capable of activating a compound with little or no toxicity into an active product; use in treating viral diseases, cancer, and genetic disorders
03/11/2003US6531285 Automated detection apparatus with a conveying means for test columns
03/11/2003US6531135 Administering to the subject an effective amount of a composition comprising a population of infectious, defective alphavirus particles in a pharmaceutically acceptable carrier
03/11/2003US6531126 Animal derived lipid
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003018821A2 Compositions and methods for treating neurodegenerative diseases
03/06/2003WO2003018788A2 Improved nitroreductase enzymes
03/06/2003WO2003018784A1 Process for producing antigen-specific human t cells and drugs
03/06/2003WO2003018783A1 ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
03/06/2003WO2003018782A2 Differentiation of neural stem cells and therapeutic use theeof
03/06/2003WO2003018779A1 Isolation of cells from neural cell populations using antibodies to fa1/dlk1
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1259